Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

J&J Finishes Tough Year With Optimism For 2021

Jan 26 2021

• By Reed Miller

Coronavirus stocks — • Source: shutterstock.com

Related Content

Johnson & Johnson Growth Led By Biosense Webster And Cerenovus

Jul 16 2019

J&J Forecasts Strong Pharma Growth In 2021, But No COVID-19 Vaccine Update

Jan 26 2021

DePuy Synthes Gains US FDA Clearance For Velys Robot For Total Knee Surgery

Jan 20 2021

J&J Bounces Back In Q3, Led By Interventional Devices

Oct 14 2020

Johnson & Johnson Unveils Details On Ottava Soft-Tissue Robot, Chasing Intuitive, Medtronic

Nov 20 2020

Related Companies

Johnson & Johnson

DePuy Synthes

Stryker Corporation

Zimmer Biomet Holdings, Inc.

Smith & Nephew plc

Biosense Webster Inc

Additional Topics

Sales & Earnings Coronavirus COVID-19 Companies Commercial Digital Health Robotic Surgery Orthopedics Surgery Medical Device

More from Robotic Surgery

More from Surgery

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window